Elan Beats Investor Fraud Claims Over Drug Prospects
U.S. District Judge Alvin Hellerstein reviewed the plaintiffs’ brief in favor of once more amending their complaints but concluded that the additional allegations did nothing to cure fatal deficiencies he pointed out at a hearing in June.
“These new allegations may offer additional details regarding plaintiffs' theory of their cases, but they do...
Already a subscriber? Click here to login